SPRO logo

SPRO

Spero Therapeutics Inc.

$2.07
+$0.07(+3.50%)
44
Overall
--
Value
45
Tech
44
Quality
Market Cap
$104.11M
Volume
396.98K
52W Range
$0.51 - $3.22
Target Price
$5.00
Order:

Income Statement

MetricTrendChart
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$2.0M$4.0M$18.1M$9.3M$18.3M$53.5M$933.0K$371.0K
Total Revenue
$2.0M$4.0M$4.7M$258.0K$3.1M$48.6M$103.8M$48.0M
GROSS PROFIT
Gross Profit
$2.0M$4.0M$18.1M$9.3M$18.3M$53.5M$103.8M$48.0M
OPERATING EXPENSES
Operating Expenses
$-43.7M$-46.8M$-81.4M$88.4M$106.2M$79.1M$82.3M$121.3M
Research & Development
$32.9M$33.9M$65.8M$67.0M$64.5M$47.6M$51.4M$96.8M
Research Expense
$32.9M$33.9M$65.8M$67.0M$64.5M$47.6M$51.4M$96.8M
Selling, General & Administrative
$10.8M$12.9M$15.6M$21.4M$41.7M$36.5M$25.6M$23.7M
General & Administrative Expenses
$10.8M$12.9M$15.6M$21.4M$41.7M$36.5M$25.6M$23.7M
Salaries & Wages
$-1.4M$-2.7M$-3.8M$4.9M$9.4M$9.1M$7.9M$7.8M
Depreciation & Amortization
$-363.0K$-409.0K$-750.0K$761.0K$646.0K$869.0K$367.0K$2.0K
Depreciation & Amortization
$-363.0K$-409.0K$-750.0K$761.0K$646.0K$869.0K$367.0K$2.0K
Other Operating Expenses
$-43.7M$-46.8M$-81.4M$1.4M$1.8M$1.7M$1.6M$1.6M
OPERATING INCOME
Operating income
$-41.7M$-42.8M$-63.2M$-79.1M$-88.0M$-42.2M$21.5M$-73.4M
EBITDA
$-39.5M$-41.9M$-60.9M$-77.5M$-87.2M$-42.9M$25.8M$-68.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
--------$1.9M$2.6M----
Intinc
$303.0K$1.1M$1.3M$401.0K$346.0K$1.1M$3.9M$4.7M
Net Non-Operating Interest Income/Expense
$303.0K$1.1M$1.3M$401.0K$346.0K$1.5M$3.9M$4.7M
Gain on Sale of Securities
----$223.0K--$204.0K$917.0K----
Other Income/Expense
$-1.5M$-43.0K$-963.0K$-432.0K$2.1M$-14.3M$14.0K$-60.0K
Other Special Charges
$1.5M$43.0K$740.0K$432.0K$-2.3M$-6.2M$-14.0K$60.0K
SPECIAL ITEMS
Restructring And Mn A Income
----------$11.6M--$877.0K
Special Income Charges
----------$-12.3M$-5.3M$-877.0K
Impairment of Capital Assets
----------$635.0K$5.3M--
PRE-TAX INCOME
EBIT
$-39.9M$-41.7M$-60.9M$-78.3M$-87.8M$-43.8M$25.4M$-68.6M
Pre-Tax Income
$-39.9M$-41.7M$-60.9M$-78.3M$-89.8M$-46.4M$-77.4M$-116.2M
INCOME TAX
Tax Provision
------------$2.6M--
NET INCOME
Net Income
$-38.7M$-41.7M$-60.9M$-78.3M$-89.8M$-46.4M$22.8M$-68.6M
Net Income (Continuing Operations)
$-38.7M$-41.7M$-60.9M$-78.3M$-89.8M$-46.4M$22.8M$-68.6M
Net Income (Discontinued Operations)
$-38.7M$-41.7M$-60.9M$-78.3M$-89.8M$-46.4M$22.8M$-68.6M
Net Income (Common Stockholders)
$-46.1M$-41.7M$-60.9M$-78.3M$-89.8M$-46.4M$22.8M$-68.6M
Normalized Income
--------$-70.9M----$-114.1M
TOTALS
Total Expenses
$-43.7M$-46.8M$-81.4M$88.4M$106.2M$79.1M$82.3M$121.3M
SHARE & EPS DATA
Average Shares Outstanding
$2.6M$16.0M$18.2M$22.4M$30.9M$37.6M$52.7M$54.0M
Average Shares Outstanding (Diluted)
$2.2M$16.0M$18.2M$22.4M--$37.6M$53.0M$54.0M
Shares Outstanding
$14.4M$17.2M$20.3M$29.5M$32.8M$52.6M$53.9M$55.9M
Basic EPS
------$-3.52$-2.91$-1.23$0.43$-1.27
Basic EPS (Continuing Operations)
------$-3.52$-2.91$-1.23$0.43$-1.27
Diluted EPS
$-17.82$-2.6$-3.35$-3.52$-2.91$-1.23$0.43$-1.27
Diluted EPS (Continuing Operations)
----------$-1.23$0.43$-1.27
OTHER METRICS
Accrued Preferred Stock Dividends
$7.4M----$549.0K--------
Minority Interests
$1.1M--------------
Other Gand A
$10.8M$12.9M$15.6M$21.4M$41.7M$36.5M$25.6M$23.7M
Otherunder Preferred Stock Dividend
$7.4M----$549.0K--------
Preferred Stock Dividends
$7.4M----$549.0K--------
Rent And Landing Fees
$10.8M$12.9M$15.6M----------
Restruct
----------$11.6M--$877.0K

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2SPRO$2.07+3.5%396.98K
3
4
5
6

Get Spero Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.